💨 Abstract

Dansy Labs Private Limited, a leading Indian pharmaceutical company, has announced a strategic USD 120 million acquisition of key assets and patents in Hong Kong and Sweden. This move is expected to significantly boost the company's research and development capabilities, expedite the advancement of next-generation products, and solidify its position as a leader in the industry.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖